Your single-source laboratory solution. FISH Probe Library
|
|
- Ernest Hardy
- 6 years ago
- Views:
Transcription
1 Your single-source laboratory solution. FISH Probe Library
2 Alphabetical List by Probe with Clinical Indication Probe Clinical Indication 1p36 (TP73)/19q13 (GLTSCR) 1q21 (CKS1B) 5q (CSF1R/RPS14) 7q (MDFIC) 13q14 (DLEU) 20q (PTPRT) 21q ALK ATM BCL2 BCL6 CBFB, inv(16) CCND1 (CYCLIN D1) CCND1/IgH, t(11;14) CDKN2A (p16) (9p21) CKS1B (1p/1q ) Centromere 4 Enumeration Probe Centromere 6 Enumeration Probe Centromere 7 Enumeration Probe Centromere 8 Enumeration Probe Centromere 9 Enumeration Probe Centromere 10 Enumeration Probe Centromere 12 Enumeration Probe Centromere 15 Enumeration Probe Centromere 17 Enumeration Probe DDIT3 (CHOP) EGFR ETV6/RUNX1 (TEL/AML), t(12;21) EWSR1 FGFR1 Follicular lymphoma, Oligodendroglioma AML, MDS AML, MDS, MPN, CLL, MDS, MPN MDS, MPN B-ALL (adult), AML, T-cell anaplastic lymphoma CLL B-ALL (adult and pediatric), AML, CML AML CLL, Mantle cell lymphoma, CLL, Mantle cell lymphoma, B-ALL (adult), Melanoma MDS, MPD, MPN MPN, CLL Myxoid/Round cell liposarcoma Glioma, B-ALL, iamp ALL Ewing sarcoma, PNET 1
3 Probe Clinical Indication FGFR3/IGH, t(4;14) FOXO1 (FKHR) HER2 IGH IGH/BCL2, t(14;18) IGH/MAF, t(14;16) IGH/MYC, t(8;14) MALT1, t(11;18) MECOM (EVI1) MET MYB MYC MYCN PDGFRA PDGFRB PML/RARA, t(15;17) PTEN RARA RB1 (13q14) RET ROS1 RREB1 RUNX1T1/RUNX1 (ETO/AML), t(8;21) SS18 (SYT) TCF3 (E2A) TCR TP53 (17p deletion) UroVysion XX/XY Alveolar rhabdomyosarcoma Breast, Gastric cancer B-cell lymphoma Burkitt lymphoma, High grade B-cell lymphoma B-ALL (adult and pediatric), AML Marginal zone lymphoma AML, MDS Melanoma Burkitt lymphoma, High grade B-cell lymphoma Neuroblastoma APL Glioma APL Retinoblastoma Melanoma AML Synovial sarcoma T-cell leukemia AML, CLL, MDS, Bladder cancer Bone marrow transplant *includes Multiple myeloma and MGUS 2
4 Hematology/Oncology Profiles Disease Probes Included B-ALL (Adult) B-ALL (Pediatric) AML CLL MDS MPN/CML MPN with Eosinophilia Multiple Myeloma Aggressive B-cell Lymphoma 21q Chromosome 6 MYC CDKN2A (p16) Centromere 4 Centromere 10 Centromere 17 ETV6/RUNX1, t(12;21) TCF3 (E2A) 5q 7q CBFB, inv(16) PML/RARA, t(15;17) RUNX1T1/RUNX1, t(8;21) 13q14 (DLEU) ATM (11q) CCND1/IGH, t(11;14)** Centromere 12 TP53 (17p) 5q 7q 20q Centromere 8 13q14 (DLEU) 20q CDKN2A (Centromere 9) Centromere 8 FGFR1 PDGFRA PDGFRB 13q14 (DLEU) CCND1/IGH, t(11;14) Centromere 7 Centromere 9 Centromere 15 CKS1B (1q21) FGFR3/IGH, t(4;14) IGH/MAF, t(14;16) TP53 (17p) BCL2 BCL6 MYC **used as differential 3
5 Solid Tumor Probes Disease Probe Breast Cancer HER2 Bladder Cancer UroVysion Colorectal Cancer Gastric Cancer Glioma Lung Cancer (Non-Small Cell) Melanoma Neuroblastoma Retinoblastoma EGFR HER2 1p/19q EGFR PTEN ALK MET RET ROS1 CCND1 Centromere 6 MYB RREB1 MYCN RB1 (13q14) Sarcomas Ewing Sarcoma Alveolar Rhabdomyosarcoma Synovial Sarcoma Myxoid/Round Cell Liposarcoma EWSR1 FOXO1 (FKHR) SS18 (SYT) DDIT3 (CHOP) 4
6 Probes Suitable for FFPE Specimens Probe Clinical Indication 1p36 (TP73)/19q13 (GLTSCR) ALK BCL2 BCL6 CBFB, inv(16) CCND1 (CYCLIN D1) CCND1/IgH, t(11;14) DDIT3 (CHOP) EGFR ETV6/RUNX1 (TEL/AML), t(12;21) EWSR1 FOXO1 (FKHR) HER2 IGH IGH/BCL2, t(14;18) IGH/MYC, t(8;14) MALT1, t(11;18) MET MYC MYCN PDGFRA PDGFRB PTEN RB1 (13q14) RET ROS1 SS18 (SYT) TCR XX/XY Follicular lymphoma, Oligodendroglioma, T-cell anaplastic lymphoma B-ALL (adult and pediatric), CML AML CLL, Mantle cell lymphoma, CLL, Mantle cell lymphoma, Myxoid/Round cell liposarcoma Glioma, B-ALL Ewing sarcoma, PNET Alveolar rhabdomyosarcoma Breast, Gastric cancer B-cell lymphoma Follicular lymphoma Burkitt lymphoma, High grade B-cell lymphoma B-ALL (adult and pediatric), AML Marginal zone lymphoma Burkitt lymphoma, High grade B-cell lymphoma Neuroblastoma Glioma Retinoblastoma Synovial sarcoma T-cell leukemia Bone marrow transplant Formalin-fixed, paraffin-embedded *includes Multiple myeloma and MGUS 5
7 Specimen Requirements Type Preferred Alternate Blood Optimal: 10 ml (adult) or 3-5 ml (pediatric) in green-top (heparin) tube Acceptable: Lavender-top (EDTA) tube Bone Marrow Optimal: 1-3 ml in green-top (heparin) tube Fixed-cell pellet from cytogenetic analysis Slides prepared from a cytogenetic analysis Fixed-cell pellet from cytogenetic analysis Acceptable: Lavender-top (EDTA) tube Slides prepared from a cytogenetic analysis Tissue Formalin-fixed, paraffin-embedded (FFPE) tissue block 4-5 unstained slides, cut to 4-5 microns thick, air-dried overnight Specimens should be maintained at room temperature. For more specific specimen requirements for individual tests, please refer to 6
8 Integrated Oncology your single-source laboratory solution. More than 490,000 tests performed on 225,000+ patients annually 1,600 contractual relationships with plans, payors, and other health care organizations across the US, some of which are on an exclusive basis Integrated with more than 700 electronic medical records (EMR) and practice management systems Menu of more than 450 genetic, pathology, IHC, and FISH tests, including 15 oncology-specific pharmacogenetic tests Staff of more than 75 pathologists, PhDs, and genetic counselors dedicated to oncology and familial cancer testing More than 65 oncology- and pathology-specific publications and presentations since 2013 Lab Locations Arizona Integrated Oncology 5005 South 40th Street Phoenix, AZ Fax New York Integrated Oncology 521 West 57th Street, Sixth Floor New York, NY Fax North Carolina LabCorp Center for Molecular Biology and Pathology 1912 Alexander Drive Research Triangle Park, NC Fax Tennessee Integrated Oncology 201 Summit View Drive, Suite 100 Brentwood, TN Fax access answers actions UroVysion is a registered trademark of Abbott Laboratories, Inc Laboratory Corporation of America Holdings. All rights reserved. onc-017-v L
TEST MENU TEST CPT CODES TAT. Chromosome Analysis Bone Marrow x 2, 88264, x 3, Days
TEST MENU CANCER/LEUKEMIA CHROMOSOME ANALYSIS Chromosome Analysis Bone Marrow 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome Analysis Bone Marrow Core 88237 x 2, 88264, 88280 x 3, 88291 4 Days Chromosome
More informationOncology Cytogenetics Diagnostic Service - User Guide 2014
Oncology Cytogenetics Diagnostic Service - User Guide 2014 Contact details Address: Cytogenetics Department 5 th Floor Tower Wing Guy s Hospital Great Maze Pond London SE1 9RT General enquiries 0207 188
More informationCYTOGENETICS INTRODUCTION SPECIAL INSTRUCTIONS ON SAMPLE COLLECTION AND HANDLING
INTRODUCTION The Cytogenetics Laboratory offers a comprehensive array of chromosome investigations for cancers, constitutional abnormalities, and prenatal and postnatal diagnosis. Analyses are performed
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY Methodology The test is based on the reported 50-gene classifier algorithm originally named PAM50 and is performed on the ncounter Dx Analysis System
More informationProsigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY GENE EXPRESSION PROFILING WITH PROSIGNA What is Prosigna? Prosigna Breast Cancer Prognostic Gene Signature Assay is an FDA-approved assay which provides
More informationSeptember 04, 2008
27027 Tourney Road Valencia, CA 91355 800 421 7110 www.specialtylabs.com Test Updates September 04, 2008 Dear Valued Client: As you may be aware, in recent years there has been a tremendous challenge in
More informationIntelliGENSM. Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community.
IntelliGENSM Integrated Oncology is making next generation sequencing faster and more accessible to the oncology community. NGS TRANSFORMS GENOMIC TESTING Background Cancers may emerge as a result of somatically
More informationMolecular Diagnosis. Nucleic acid based testing in Oncology
Molecular Diagnosis Nucleic acid based testing in Oncology Objectives Describe uses of NAT in Oncology Diagnosis, Prediction, monitoring. Genetics Screening, presymptomatic testing, diagnostic testing,
More informationNucleic Acid Testing - Oncology. Molecular Diagnosis. Gain/Loss of Nucleic Acid. Objectives. MYCN and Neuroblastoma. Molecular Diagnosis
Nucleic Acid Testing - Oncology Molecular Diagnosis Nucleic acid based testing in Oncology Gross alterations in DNA content of tumors (ploidy) Gain/Loss of nucleic acids Markers of Clonality Oncogene/Tumor
More informationmolecular oncology services
Molecular Oncology molecular oncology services ATIENTS.ANSWERS.RESULTS. www.aruplab.com/oncology MARCH 2018 Information in this brochure is current as of March 2018. All content is subject to change. lease
More informationHEMATOPATHOLOGY SERVICES
HEMATOPATHOLOGY SERVICES Know what your patient s future holds, NOW. Driven by patient care, GoPath Laboratories has set a new standard for hematologic cancer testing. thick, 2 slides per probe minimum
More informationMolecular. Oncology & Pathology. Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine. Liquid Biopsy.
Molecular Oncology & Pathology Hereditary Cancer Somatic Cancer Liquid Biopsy Next-Gen Sequencing qpcr Sanger Sequencing Diagnostic, Prognostic, Therapeutic, and Predisposition Tests in Precision Medicine
More informationNeoTYPE Cancer Profiles
NeoTYPE Cancer Profiles Multimethod Analysis of 25+ Hematologic Diseases and Solid Tumors Anatomic Pathology FISH Molecular The next generation of diagnostic, prognostic, and therapeutic assessment NeoTYPE
More informationOut-Patient Billing CPT Codes
Out-Patient Billing CPT Codes Updated Date: August 3, 08 Client Billed Molecular Tests HPV DNA Tissue Testing 8764 No Medicare Billed - Molecular Tests NeoARRAY NeoARRAY SNP/Cytogenetic No 89 NeoLAB NeoLAB
More informationClinical Cytogenetic Services
Clinical Cytogenetic Services Constitutional Diagnostic Services Neoplastic Diagnostic Services FISH (Fluorescence In Situ Hybridization) Cytogenetics Laboratory Phone: 509.434.1050 Toll Free: 800.541.7891
More informationOutline. Chromosomal analysis FISH. Chromosomal abnormalities in cancer. Clinical application of cytogenetics. Procedure Nomenclature
Outline Chromosomal analysis Procedure Nomenclature FISH Procedure Probes Multicolor-FISH CGH Chromosomal abnormalities in cancer CML, MPD, MDS, AML, ALL, CLL, myeloma, lymphoma Clinical application of
More informationNeoTYPE Cancer Profiles
NeoTYPE Cancer Profiles 30+ Multimethod Assays for Hematologic Diseases and Solid Tumors Molecular FISH Anatomic Pathology The next generation of diagnostic, prognostic, and therapeutic assessment What
More informationPhenoPath. Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA
PhenoPath Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA C urrent diagnosis of B cell non-hodgkin lymphoma (B-NHL) is based on the 2008 WHO Classification of Tumours of Haematopoietic and Lymphoid
More informationHSL-Advanced Diagnostics 2018 / 19 Test & Service List
HSL-Advanced Diagnostics 2018 / 19 Test & Service List 2018/19 TEST & SERVICE LIST Haematoxylin & Eosin H&E H&E per slide Routine Immunohistochemistry Immunohistochemical demonstration of an antigen in
More informationKREATECH DIAGNOSTICS SOLID TUMORS
KREATECH DIAGNOSTICS SOLID TUMORS RF POSEIDON SOLUTIONS FOR SOLID TUMOR FISH DIAGNOSTICS TABLE OF CONTENTS Breast Cancer 3 Bladder Cancer 4 Cervical Cancer 4 Lung Cancer 5 Prostate Cancer 6 Thyroid Carcinoma
More informationDivision of Genomic Diagnostics CANCER GENOMIC TEST REQUISITION Page 1 of 6
Page 1 of 6 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostic Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 Patient
More informationAugust 17, Dear Valued Client:
August 7, 08 Re: CMS Announces 6-Month Period of Enforcement Discretion for Laboratory Date of Service Exception Policy Under the Medicare Clinical Laboratory Fee Schedule (the 4 Day Rule ) Dear Valued
More informationACMG/CAP Cytogenetics CY
www.cap.org Cytogenetics Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services ACMG/CAP Cytogenetics CY Analyte CY Challenges per Shipment
More informationDIRECTORY OF SERVICES
DIRECTORY OF SERVICES 1916 Patterson Street, Suite 400 Nashville, TN 37203 (615) 327-4532 (800)331-GENE www.geneticsassociates.com GENETICS ASSOCIATES, Inc. 1916 Patterson Street, Suite 400 Nashville,
More informationThe Center for PERSONALIZED DIAGNOSTICS
The Center for PERSONALIZED DIAGNOSTICS Precision Diagnostics for Personalized Medicine A joint initiative between The Department of Pathology and Laboratory Medicine & The Abramson Cancer Center The (CPD)
More informationHematology Diagnostic Services
Cleveland Clinic Laboratories Hematology Diagnostic Services Trust in us for everything you need in a reference lab. Our Mission The Pathology and Laboratory Medicine Institute contributes to excellent
More informationMolecular Genetics of Paediatric Tumours. Gino Somers MBBS, BMedSci, PhD, FRCPA Pathologist-in-Chief Hospital for Sick Children, Toronto, ON, CANADA
Molecular Genetics of Paediatric Tumours Gino Somers MBBS, BMedSci, PhD, FRCPA Pathologist-in-Chief Hospital for Sick Children, Toronto, ON, CANADA Financial Disclosure NanoString - conference costs for
More informationThe Power of Observation
The Power of Observation An Introduction.. Scanning electron micrograph of several human chromosomes. Source: J.B. Rattner and C.C. Lin, Cell 42 (1985), p. 291. 1842: Chromosomes first observed in plant
More informationLab Guide 2018 Diagnostic Genomic Division(DGD)
Lab Guide 2018 Diagnostic Genomic Division(DGD) Diagnostic Genomic Division DGD lab Guide Page 1 of 74 Cytogenetics Section Title ACUTE MYELOID LEUKEMIA PANEL BY FISH ITEM Days test is performed Turnaround
More informationTargeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018
Targeted Agent and Profiling Utilization Registry (TAPUR ) Study February 2018 Precision Medicine Therapies designed to target the molecular alteration that aids cancer development 30 TARGET gene alterations
More informationDNA-FISH Probe Catalog Empowering Personalized Cancer Treatment.
Hematologic Diseases ALCL ALL AML CLL CML MM MDS NHL Solid Tumors Empowering Personalized Cancer Treatment Breast Colon/Rectal Cervical Lung DNA-FISH Probe Catalog www.cancergeneticsitalia.com 2011-2012
More informationCost-Effective Strategies in the Workup of Hematologic Neoplasm. Karl S. Theil, Claudiu V. Cotta Cleveland Clinic
Cost-Effective Strategies in the Workup of Hematologic Neoplasm Karl S. Theil, Claudiu V. Cotta Cleveland Clinic In the past 12 months, we have not had a significant financial interest or other relationship
More informationABBOTT MOLECULAR ONCOLOGY AND GENETICS
DESCRIPTOR, 9/12, ALL CAPS ABBOTT MOLECULAR ONCOLOGY AND GENETICS 2015-2016 Product Catalog Area for placed imagery Only use imagery that is relevant to the communication CHOOSE TRANSFORMATION See where
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Haematopathology and Oncology Diagnostic Services (HODS) Addenbrookes Hospital Hills Road Cambridge CB2 0QQ Contact: Brian Warner Tel: +44
More informationRole of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
More informationSignificance of Chromosome Changes in Hematological Disorders and Solid Tumors
Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome 3.3 X 10 9 DNA basepairs Estimated genetic constitution 30,000
More informationMolecular pathology/genetics of sarcomas
Molecular pathology/genetics of sarcomas Gunhild Mechtersheimer Institute of Pathology, University of Heidelberg Sarkomkonferenz: 17.03.2011 Berlin Characterization of soft tissue sarcomas / STS (~ 1%
More informationXCyting DNA FISH Probes
XCyting DNA FISH Catalog 2017/18 MetaSystems 1. Industriestr. 7 D-68804 Altlussheim Germany Phone: +49 6205 2927610 Fax: +49 6205 2927629 E-Mail info: info@metasystems-probes.com E-Mail orders: orders@metasystems-probes.com
More informationSignificance of Chromosome Changes in Hematological Disorders and Solid Tumors
Significance of Chromosome Changes in Hematological Disorders and Solid Tumors Size of Components of Human Genome Size of haploid genome! Estimated genetic constitution! Size of average chromosome
More information2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes
Acute basophilic leukemia 9870/3 Acute biphenotypic leukemia [OBS] 9805/3 Acute erythroid leukemia 9840/3 Acute megakaryoblastic leukemia 9910/3 Acute monoblastic and monocytic leukemia 9891/3 Acute myeloid
More information2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes
Malignant lymphoma, NOS 9590/3 Non-Hodgkin lymphoma, NOS 9591/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma 9596/3 Primary
More informationZytoLight SPEC FGF3,4,19/CEN 11 Dual Color Probe
ZytoLight SPEC FGF3,4,19/CEN 11 Dual Color Probe The ZytoLight SPEC FGF3,4,19/CEN 11 Dual Color Probe is designed for the detection of amplifications of the chromosomal region harboring the genes FGF3,
More informationHaematology Probes for Multiple Myeloma
Haematology Probes for Multiple Myeloma MULTIPLE MYELOMA Multiple myeloma (MM) is a plasma cell neoplasm, characterised by the accumulation of clonal plasma cells in the bone marrow and by very complex
More informationCLL Complete SM Report
Reported: 02/01/2012 Σ CGI ID No:5 Client:r Client Address: CLINICAL DATA: Lymphoma No CBC results provided. CLL Complete SM Report FINAL DIAGNOSIS: CD19+ B cell lymphoma, ZAP-70 + (44%), with borderline
More informationFor finding your local dealer visit
Catalogue 2017 For finding your local dealer visit DISCLAIMER All information is supplied without liability. All product data are subject to changes. The information contained herein is believed to be
More informationCombinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation
Major subgroups according to the World Health Organisation (WHO) Classification Myeloproliferative neoplasms (MPN) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or
More informationCytogenetics Update. Lynda J Campbell
Cytogenetics Update Lynda J Campbell lynda.campbell@svhm.org.au Nowell and Hungerford, 1960 Ph Janet Rowley showed the Ph chromosome to be a balanced rearrangement: t(9;22) 9 22 Acute lymphoblastic leukaemia
More informationNext Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making
Next Generation Sequencing in Clinical Practice: Impact on Therapeutic Decision Making November 20, 2014 Capturing Value in Next Generation Sequencing Symposium Douglas Johnson MD, MSCI Vanderbilt-Ingram
More informationGENETIC MARKERS IN LYMPHOMA a practical overview. P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute
GENETIC MARKERS IN LYMPHOMA a practical overview P. Heimann Dpt of Medical Genetics Erasme Hospital - Bordet Institute B and T cell monoclonalities Rearrangement of immunoglobin and TCR genes may help
More informationChapter 2 Classical and Molecular Cytogenetic Analysis of Hematolymphoid Disorders
Chapter 2 Classical and Molecular Cytogenetic Analysis of Hematolymphoid Disorders Mark A. Micale Keywords Myelodysplastic/myeloproliferative disorders Leukemia Lymphoma Fluorescence in situ hybridization
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the author to give readers additional information about his work. Supplement to: Croce CM. Oncogenes and cancer. N Engl J Med 2008;358:502-11.
More informationClinical Validation of Cytocell Pathology Probes
Clinical Validation of Cytocell Pathology Probes Shivanand Richardson Specialized Technician Molecular Pathology Department of Pathology, University Medical Center Utrecht The Netherlands 5th annual Cytocell
More informationEXT ADDRESS CITY LAST NAME ID NUMBER PT. ADDRESS CITY INSURANCE PROVIDER. 0 Other. 0 IGH/B-cell cionaliry (PCR)
THE UNIVERSITY OF TEXAS *Required Fields PHYSICIAN! FACILITY/ CLIENT INFORMATION MDAndersonefief &ter MaltgararEettcy 'REQUESTING PHYSICIAN Division of Pathology! Laboratory Medicine Services Test Requisition
More informationKHMDC Oncology Cytogenetics User Guide
KHMDC Oncology Cytogenetics User Guide Introduction Viapath is a unique partnership of clinical, scientific and operational expertise, with a mission to transform pathology services in the UK. Our organisation
More informationIntroducing Western Diagnostic s Genomic Pathology
Genetic Testing Introducing Western Diagnostic s Genomic Pathology As one of Australia s longest running and nationally coordinated DNA testing organisations, Western Diagnostic s Genomic Pathology perform
More informationImmunopathology of Lymphoma
Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.
More informationUse of MYC, BCL2 and BCL6 FISH for investigations of high grade B cell lymphoma
Use of MYC, BCL2 and BCL6 FISH for investigations of high grade B cell lymphoma Dr Anthony Bench Haematopathology and Oncology Diagnostic Service Cambrıdge Unıversıty Hospitals NHS Foundatıon Trust Cambridge
More informationGenetic/genomic diagnosis for personalized cancer treatment
Genetic/genomic diagnosis for personalized cancer treatment Yao-Shan Fan, MD, PhD Professor, Pathology Director, Cytogenetics & Molecular Diagnostics The Achilles heel A one-step remedy. Cancer cells acquire
More informationMOC MGP General Molecular Genetics I (Mandatory 75-Question Module) analytical measurement range; CLSI MM06-A2 PCR assay performance and validation
MOC MGP General Molecular Genetics I (Mandatory 75-Question Module) analytical measurement range; CLSI MM06-A2 PCR assay performance and validation assay validation; sensitivity; PCR interpretation and
More informationClinical Grade Genomic Profiling: The Time Has Come
Clinical Grade Genomic Profiling: The Time Has Come Gary Palmer, MD, JD, MBA, MPH Senior Vice President, Medical Affairs Foundation Medicine, Inc. Oct. 22, 2013 1 Why We Are Here A Shared Vision At Foundation
More informationComparison of FISH, CpG-stimulation, chromosomal microarray and mate pair sequencing in 20 patients with CLL or lymphoma
Comparison of FISH, CpG-stimulation, chromosomal microarray and mate pair sequencing in 20 patients with CLL or lymphoma Stephanie Smoley Cancer Genomics Consortium August 9 th, 2017 2016 MFMER slide-1
More informationa resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation
a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral
More informationObjectives. Morphology and IHC. Flow and Cyto FISH. Testing for Heme Malignancies 3/20/2013
Molecular Markers in Hematologic Malignancy: Ways to locate the needle in the haystack. Objectives Review the types of testing for hematologic malignancies Understand rationale for molecular testing Marcie
More informationGenetic Testing Oncology
Genetic Testing Oncology Policy Number: Original Effective Date: MM.02.010 05/01/2010 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 05/01/2014 Section: Medicine Place(s) of Service:
More informationMolecular Hematopathology
Molecular Hematopathology Charles E. Hill, MD, PhD Emory University School of Medicine April 2013 The Association for Molecular Pathology Education. Innovation and Improved Patient Care. Advocacy. www.amp.org
More informationUTILIZATION OF A SNP MICROARRAY FOR CHRONIC LYMPHOCYTIC LEUKEMIA: EFFICACY, INFORMATIVE FINDINGS AND PROGNOSTIC CAPABILITIES
UTILIZATION OF A SNP MICROARRAY FOR CHRONIC LYMPHOCYTIC LEUKEMIA: EFFICACY, INFORMATIVE FINDINGS AND PROGNOSTIC CAPABILITIES S Schwartz, Z Hosseini, S Schepis, P Papenhausen Laboratory Corporation of America
More informationThe spectrum of flow cytometry of the bone marrow
The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests
More informationPatricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope
Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope National Medical Center Disclosures I have no disclosures
More informationDiagnostic test Suggested website label Description Hospitals available
Diagnostic test Suggested website label Description Hospitals available Abbott Molecular Inc, PATHVYSION HER-2 DNA Probe Kit (FISH) PathVysion kit A diagnostic tool used to determine whether a particular
More informationJeanne Palmer February 26, 2017 Mayo Clinic, Phoenix, AZ
Jeanne Palmer February 26, 2017 Mayo Clinic, Phoenix, AZ What is acute leukemia? Cancer of the white blood cells Acute leukemia- Acute myelogenous leukemia Acute myeloid leukemia Myelofibrosis- Blast phase
More informationSALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length.
SALSA MLPA probemix P175-A3 Tumour Gain Lot A3-0714: As compared to the previous version A2 (lot A2-0411), nine probes have a small change in length. This SALSA probemix is for basic research only! This
More informationKreatech TM. Solutions for Diagnosis in Solid Tumor Samples. Kreatech FISH Probes
Kreatech TM Solutions for Diagnosis in Solid Tumor Samples Kreatech FISH Probes Kreatech FISH Probes are the latest advancement in DNA in situ hybridization. The probes are constructed using the REPEAT-FREE
More informationFACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
More informationFrom Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport
From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative
More informationPediatric Oncology & Pathology Services
Pediatric Oncology & Pathology Services Anatomic Pathology Flow Cytometry Cytogenetics Pharma Services Diagnostic, Prognostic, Predictive, and Predisposition Testing Pediatric Oncology & Pathology Services
More informationPredictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities
Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities Sujana Movva 1, Wenhsiang Wen 2, Wangjuh Chen 2, Sherri Z. Millis 2, Margaret von Mehren 1, Zoran
More informationSureSelect Cancer All-In-One Custom and Catalog NGS Assays
SureSelect Cancer All-In-One Custom and Catalog NGS Assays Detect all cancer-relevant variants in a single SureSelect assay SNV Indel TL SNV Indel TL Single DNA input Single AIO assay Single data analysis
More informationCurrent and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian
Current and future applications of Molecular Pathology Kathy Walsh Clinical Scientist NHS Lothian Molecular Pathology in Solid tumours Cancer type Genes tested Purpose Associated treatments Non small cell
More informationPersonalised cancer care Information for Medical Specialists. A new way to unlock treatment options for your patients
Personalised cancer care Information for Medical Specialists A new way to unlock treatment options for your patients Contents Optimised for clinical benefit 4 Development history 4 Full FIND IT panel vs
More informationMohammed El-Khateeb. Tumor Genetics. MGL-12 July 21 st 2013 台大農藝系遺傳學 Chapter 22 slide 1
Mohammed El-Khateeb Tumor Genetics MGL-12 July 21 st 2013 台大農藝系遺傳學 601 20000 Chapter 22 slide 1 Cellular Basis of Cancer Cancer is a collection of diseases characterized by abnormal and uncontrolled growth
More informationCurrent as of June 29, 2018 Prices subject to change without notice
Current as of June 29, 2018 Prices subject to change without notice Clinical: 465 Henry Mall Madison, WI 53706-1578 (800) 862-1013 http://www.slh.wisc.edu 465 Henry Mall Madison, WI 53706-1578 Phone: (608)
More informationPediatric Pathology Grossing Guidelines
When you get a case that should/could be for Pediatric Pathology, show it to the gross room supervisor or page Dr. Goldstein at 31418 before you cut it in. If it is the weekend or late at night, page the
More information7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour
7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic
More information(Fully automated FISH Analysis for B-cell Chronic Lymphocytic Leukemia: a faster alternative to manual double scoring)
Routine integration of fully automated image analysis of Kreatech CLL FISH Probes, using the CytoVision GSL Scanning System (Fully automated FISH Analysis for B-cell Chronic Lymphocytic Leukemia: a faster
More informationDifferential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital
Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic
More informationReporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota
Reporting cytogenetics Can it make sense? Daniel Weisdorf MD University of Minnesota Reporting cytogenetics What is it? Terminology Clinical value What details are important Diagnostic Tools for Leukemia
More informationCopy number and somatic mutations drive tumors
Detection of copy number alterations, ploidy and loss of heterozygosity across the genome in FFPE specimens Utility for diagnosis and treatment with comparison to FISH-based and as a complement to sequencing
More informationIntroduction to Cytogenetics
Introduction to Cytogenetics Catherine McCarthy Pathology Qld Cytogenetic abnormalities constitutional acquired: clonal: related or unrelated non-clonal Investigating constitutional abnormalities peripheral
More informationApproach to Core Biopsy Specimens
BDIAP 108th Symposium on Haematopathology Joint Meeting of the BDIAP and BLPG at-bristol, Anchor Road, Harbourside, Bristol BS1 5DB 15th - 17th May 2014 Approach to Core Biopsy Specimens Dr Stefan Dojcinov
More informationClinical Cytogenomics Laboratory. Laboratory. Leading diagnostics for better medicine. Beaumont
Clinical Cytogenomics Laboratory Leading diagnostics for better medicine Beaumont Laboratory Beaumont Laboratory s Clinical Cytogenomics Lab Genome decoding is essential Knowledge of variations in genome
More informationSurgical Pathology Evening Specialty Conference USCAP 2015
Surgical Pathology Evening Specialty Conference USCAP 2015 John R. Goldblum, M.D. Chairman, Department of Pathology, Cleveland Clinic Professor of Pathology, Cleveland Clinic Lerner College of Medicine
More informationIntegrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University
Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic
More informationRecommended Timing for Transplant Consultation
REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org
More informationCancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous
Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors
More informationThe new Leeds Solid Tumour Molecular Oncology Diagnostics Service. Paul Roberts, Genetics, Leeds
The new Leeds Solid Tumour Molecular Oncology Diagnostics Service Paul Roberts, Genetics, Leeds Molecular Oncology services pre-2013 DNA lab Germline cancer Cytogenetics lab FISH, cell culture, molecular
More informationMOLECULAR SERVICES. mlabs.umich.edu
MOLECULAR SERVICES mlabs.umich.edu 800.862.7284 PICTURED ON LEFT IS MARWAN TAYEH, PH.D, CLINICAL ASSISTANT PROFESSOR, PEDIATRICS - GENETICS, ON RIGHT IS TODD ACKLEY, LABORATORY MANAGER MLabs is a full-service
More informationHEMATOPATHOLOGY DIAGNOSIS & SUBTYPING. Use of IHC. Use of Polymerase Chain Reaction (PCR) Use of Flow Cytometry
HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING HEMATOPATHOLOGY DIAGNOSIS & SUBTYPING The 2008 WHO classification system for tumors of hematopoietic and lymphoid tissues specifies that various combinations of immunophenotypic
More information